Beyond just peptide antigens: the complex world of peptide-based cancer vaccines

Beyond just peptide antigens: the complex world of peptide-based cancer vaccines

Peptide-based cancer vaccines rely upon the strong activation of the adaptive immune response to elicit its effector function. They have shown to be highly specific and safe, but have yet to prove themselves as an efficacious treatment for cancer in the clinic. This is for a variety of reasons, incl...

Bibliografski detalji
Glavni autori:	Stephens, AJ, Burgess-Brown, NA, Jiang, S
Format:	Journal article
Jezik:	English
Izdano:	Frontiers Media 2021

Slični predmeti

Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines
od: Alexander J. Stephens, i dr.
Izdano: (2021-06-01)

Cancer-Testis Antigen Peptide Vaccine for Cancer Immunotherapy: Progress and Prospects
od: Xiao Wei, i dr.
Izdano: (2019-05-01)

Adrenomedullin: Not Just Another Gastrointestinal Peptide
od: Sonia Martínez-Herrero, i dr.
Izdano: (2022-01-01)

Prevention of EAE by tolerogenic vaccination with PEGylated antigenic peptides
od: Jennifer Pfeil, i dr.
Izdano: (2021-08-01)

Peptide Vaccines for Cancer
od: Kono K
Izdano: (2013-10-01)

Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems
od: Ahmed O. Shalash, i dr.
Izdano: (2022-04-01)

Adjuvants for peptide-based cancer vaccines
od: Willem W Overwijk, i dr.
Izdano: (2016-09-01)

Peptide-based vaccine for cancer therapies
od: Luigi Buonaguro, i dr.
Izdano: (2023-08-01)

Presentation of antigenic peptides by products of the major histocompatibility complex.
od: Fairchild, P
Izdano: (1998)

Developing recombinant overlapping peptides of prostate-specific antigen as vaccine
od: Chan, S
Izdano: (2022)

Role of Linker Length and Antigen Density in Nanoparticle Peptide Vaccine
od: Chintan H. Kapadia, i dr.
Izdano: (2019-03-01)

Corrigendum: Peptide-based vaccine for cancer therapies
od: Luigi Buonaguro, i dr.
Izdano: (2023-10-01)

Assessment of Crosslinkers between Peptide Antigen and Carrier Protein for Fusion Peptide-Directed Vaccines against HIV-1
od: Li Ou, i dr.
Izdano: (2022-11-01)

1379 Novel backbone-modified analogues of antigenic peptides improve immunogenic capabilities of anti-tumor peptide vaccines
od: Douglas McNeel, i dr.
Izdano: (2023-11-01)

Low-complexity sequences and single amino acid repeats: not just "junk" peptide sequences.
od: Haerty, W, i dr.
Izdano: (2010)

TEIPP peptides: exploration of unTAPped cancer antigens
od: Koen A. Marijt, i dr.
Izdano: (2019-08-01)

In vitro evaluation of dual-antigenic PV1 peptide vaccine in head and neck cancer patients
od: San Jiun Chai, i dr.
Izdano: (2019-01-01)

Photochemical Internalization of Peptide Antigens Provides a Novel Strategy to Realize Therapeutic Cancer Vaccination
od: Markus Haug, i dr.
Izdano: (2018-04-01)

Peptide Vaccine Therapy in Colorectal Cancer
od: Shi-Yu Yang, i dr.
Izdano: (2012-08-01)

Peptide-Based Immunotherapeutics and Vaccines
od: Pedro A. Reche, i dr.
Izdano: (2014-01-01)

Peptide-Based Vaccines for Tuberculosis
od: Wenping Gong, i dr.
Izdano: (2022-01-01)

Potential association factors for developing effective peptide-based cancer vaccines
od: Chongming Jiang, i dr.
Izdano: (2022-07-01)

Overlapping synthetic peptides as vaccines
od: Jiang, S, i dr.
Izdano: (2006)

Computer-aided prediction of antigen presenting cell modulators for designing peptide-based vaccine adjuvants
od: Gandharva Nagpal, i dr.
Izdano: (2018-07-01)

Peptide‐Based Cancer Vaccine Delivery via the STINGΔTM‐cGAMP Complex
od: He, Yanpu, i dr.
Izdano: (2022)

Current Peptide and Protein Candidates Challenging HIV Therapy beyond the Vaccine Era
od: Koollawat Chupradit, i dr.
Izdano: (2017-09-01)

Antigen presentation. Naturally processed peptides.
od: Elliott, T, i dr.
Izdano: (1990)

Tolerogenic Immunomodulation by PEGylated Antigenic Peptides
od: Jennifer Pfeil, i dr.
Izdano: (2020-10-01)

Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
od: Kunal Nepali, i dr.
Izdano: (2022-09-01)

1040-H Coupling DNA barcoding and multi-peptide screening: unveiling T cell receptor and antigenic peptide relationships in complex samples
od: Miranda Byrne-Steele, i dr.
Izdano: (2023-11-01)

Synthetic peptide vaccines
od: O. V. Sergeyev, i dr.
Izdano: (2016-02-01)

Peptide Vaccines for Leishmaniasis
od: Rory C. F. De Brito, i dr.
Izdano: (2018-05-01)

Peptide-Based Immunotherapeutics and Vaccines 2017
od: Pedro Reche, i dr.
Izdano: (2018-01-01)

Peptide-Based Immunotherapeutics and Vaccines 2015
od: Pedro Reche, i dr.
Izdano: (2015-01-01)

Antitumor Peptide-Based Vaccine in the Limelight
od: Takumi Kumai, i dr.
Izdano: (2022-01-01)

Editorial: Synthetic peptide vaccine platforms targeting tumor-specific antigens: advances and challenges
od: Reid M. Rubsamen, i dr.
Izdano: (2024-02-01)

MHC-restricted antigen presentation and recognition: constraints on gene, recombinant and peptide vaccines in humans
od: Cunha-Neto E.
Izdano: (1999-01-01)

Light control of the peptide-loading complex synchronizes antigen translocation and MHC I trafficking
od: Jamina Brunnberg, i dr.
Izdano: (2021-03-01)

Chaperone-mediated MHC-I peptide exchange in antigen presentation
od: Jiansheng Jiang, i dr.
Izdano: (2024-05-01)

Molecular characterization of antigen-peptide pulsed dendritic cells: immature dendritic cells develop a distinct molecular profile when pulsed with antigen peptide.
od: Amy X Yang, i dr.
Izdano: (2014-01-01)